Detailed Mechanism Funding and Narrative

Years of mechanism: 2016 2017 2018 2019 2020

Details for Mechanism ID: 18215
Country/Region: Kenya
Year: 2016
Main Partner: Coptic Hospital
Main Partner Program: NA
Organizational Type: FBO
Funding Agency: HHS/CDC
Total Funding: $4,341,355 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $808,767
Care: TB/HIV (HVTB) $254,639
Care: Pediatric Care and Support (PDCS) $147,242
Testing: HIV Testing and Counseling (HVCT) $169,184
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $827,662
Treatment: Adult Treatment (HTXS) $1,903,560
Treatment: Pediatric Treatment (PDTX) $230,301
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
GEND_GBV By PEP service provision (related to sexual violence services provided) 2017 38
GEND_GBV By type of service: Physical and/or Emotional Violence (Other Post-GBV Care) 2017 88
GEND_GBV By type of service: Sexual Violence (Post-Rape Care) 2017 38
GEND_GBV Number of people receiving post-GBV care 2017 126
HTS_TST Age/sex: <1 2017 1,033
HTS_TST Age/sex: 1-9 2017 19,006
HTS_TST Age/sex: 10-14 Female 2017 1,437
HTS_TST Age/sex: 10-14 Male 2017 1,189
HTS_TST Age/sex: 15-19 Female 2017 12,213
HTS_TST Age/sex: 15-19 Male 2017 10,357
HTS_TST Age/sex: 20-24 Female 2017 26,200
HTS_TST Age/sex: 20-24 Male 2017 21,646
HTS_TST Age/sex: 25-49 Female 2017 73,166
HTS_TST Age/sex: 25-49 Male 2017 58,718
HTS_TST Age/sex: 50+ Female 2017 6,374
HTS_TST Age/sex: 50+ Male 2017 5,261
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2017 14,886
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2017 11,572
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2017 124,192
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2017 96,750
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2017 247,400
HTS_TST Service Delivery Point (Facility): Index testing 2017 3,581
HTS_TST Service Delivery Point (Facility): Inpatient 2017 13,775
HTS_TST Service Delivery Point (Facility): Other PITC 2017 1,953
HTS_TST Service Delivery Point (Facility): Outpatient 2017 145,328
HTS_TST Service Delivery Point (Facility): Pediatric 2017 2,559
HTS_TST Service Delivery Point (Facility): PMTCT 2017 13,776
HTS_TST Service Delivery Point (Facility): TB Clinics 2017 540
HTS_TST Service Delivery Point (Facility): VCT 2017 60,980
HTS_TST Service Delivery Point (Facility): VMMC 2017 4,908
HTS_TST Sum of Age/Sex disaggregates 2017 216,561
HTS_TST Sum of Aggregated Age/Sex <15 2017 26,458
HTS_TST Sum of Aggregated Age/Sex 15+ 2017 220,942
HTS_TST Sum of Aggregated Age/Sex disaggregates 2017 247,400
HTS_TST_POS Test Result by Age and Sex: Positive: 10-14 Female 2017 8
HTS_TST_POS Test Result by Age and Sex: Positive: 10-14 Male 2017 6
HTS_TST_POS Test Result by Age and Sex: Positive: 15-19 Female 2017 120
HTS_TST_POS Test Result by Age and Sex: Positive: 15-19 Male 2017 65
HTS_TST_POS Test Result by Age and Sex: Positive: 20-24 Female 2017 521
HTS_TST_POS Test Result by Age and Sex: Positive: 20-24 Male 2017 297
HTS_TST_POS Test Result by Age and Sex: Positive: 25-49 Female 2017 2,704
HTS_TST_POS Test Result by Age and Sex: Positive: 25-49 Male 2017 1,550
HTS_TST_POS Test Result by Age and Sex: Positive: 50+ Female 2017 281
HTS_TST_POS Test Result by Age and Sex: Positive: 50+ Male 2017 165
HTS_TST_POS Test Result by Age: Positive: <1 2017 2
HTS_TST_POS Test Result by Age: Positive: 1-9 2017 124
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Female 2017 389
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Male 2017 221
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Female 2017 4,178
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Male 2017 2,356
PMTCT_ART Already on ART at beginning of current pregnancy 2017 1,384
PMTCT_ART New on ART 2017 488
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 12,050
PMTCT_EID By infants who received a virologic test within 2 months of birth 2017 1,444
PMTCT_EID By infants who received their first virologic HIV test between 2 and 12 months of age 2017 290
PMTCT_EID Number of infants with a positive virological test result within 12 months of birth 2017 23
PMTCT_EID Number of infants with a positive virological test result within 2 months of birth 2017 20
PMTCT_EID Sum of Infant Age disaggregates 2017 1,734
PMTCT_STAT By Age (DREAMS SNUs ONLY): <15 2017 63
PMTCT_STAT By Age (DREAMS SNUs ONLY): 15-19 2017 322
PMTCT_STAT By Age (DREAMS SNUs ONLY): 20-24 2017 2,064
PMTCT_STAT By Age (DREAMS SNUs ONLY): 25-49 2017 4,403
PMTCT_STAT By: Known positives at entry 2017 1,600
PMTCT_STAT By: Number of new positives identified 2017 642
PMTCT_STAT Number of new ANC and L&D clients 2017 12,050
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 12,050
PMTCT_STAT Required only for DREAMS Countries - By Number of known positives: <15 2017 3
PMTCT_STAT Required only for DREAMS Countries - By Number of known positives: 15-19 2017 21
PMTCT_STAT Required only for DREAMS Countries - By Number of known positives: 20-24 2017 142
PMTCT_STAT Required only for DREAMS Countries - By Number of known positives: 25-49 2017 833
PMTCT_STAT Required only for DREAMS Countries - By Number of known positives: 50+ 2017 167
PMTCT_STAT Required only for DREAMS Countries - By Number of new positives: <15 2017 1
PMTCT_STAT Required only for DREAMS Countries - By Number of new positives: 15-19 2017 11
PMTCT_STAT Required only for DREAMS Countries - By Number of new positives: 20-24 2017 83
PMTCT_STAT Required only for DREAMS Countries - By Number of new positives: 25-49 2017 260
PMTCT_STAT Required only for DREAMS Countries - By Number of new positives: 50+ 2017 53
PMTCT_STAT Sum of Positives Status disaggregates 2017 2,242
PMTCT_STAT_den Required only for DREAMS Countries - Denominator: <15 2017 63
PMTCT_STAT_den Required only for DREAMS Countries - Denominator: <15-19 2017 322
PMTCT_STAT_den Required only for DREAMS Countries - Denominator: 20-24 2017 2,064
PMTCT_STAT_den Required only for DREAMS Countries - Denominator: 25-49 2017 4,403
TB_ART Aggregated Age/Sex: Female <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 21
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 329
TB_ART Aggregated Age/Sex: Male <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 26
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 383
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2017 759
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2017 759
TB_SCREENDX [Sub-Disagg of Screen Result] Specimen Sent: Specimen sent for bacteriologic diagnosis of active TB 2017 12,102
TB_SCREENDX [Sub-Disagg of Specimen Sent] Diagnostic Test: Xpert MTB/RIF assay 2017 12,102
TB_SCREENDX Screen Result: Screened Positive for TB 2017 13,445
TB_SCREENDX Screened for TB by Age/Sex: 15+ Female 2017 41,891
TB_SCREENDX Screened for TB by Age/Sex: 15+ Male 2017 20,682
TB_SCREENDX Screened for TB by Age/Sex:<15 Female 2017 2,256
TB_SCREENDX Screened for TB by Age/Sex:<15 Male 2017 2,390
TB_SCREENDX The number of PLHIV who were screened for TB symptoms at the last clinical visit at a HIV facility during the reporting period 2017 67,218
TB_STAT Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 39
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 538
TB_STAT Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 48
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 629
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2017 1,254
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2017 1,254
TX_CURR Age/Sex: <1 2017 30
TX_CURR Age/Sex: <1-9 2017 2,982
TX_CURR Age/Sex: 10-14 Female 2017 789
TX_CURR Age/Sex: 10-14 Male 2017 845
TX_CURR Age/Sex: 15-19 Female 2017 1,780
TX_CURR Age/Sex: 15-19 Male 2017 1,012
TX_CURR Age/Sex: 20-24 Female 2017 3,610
TX_CURR Age/Sex: 20-24 Male 2017 985
TX_CURR Age/Sex: 25-49 Female 2017 30,482
TX_CURR Age/Sex: 25-49 Male 2017 13,964
TX_CURR Age/Sex: 50+ Female 2017 6,019
TX_CURR Age/Sex: 50+ Male 2017 4,720
TX_CURR Aggregated Age/Sex: <15 Female 2017 2,256
TX_CURR Aggregated Age/Sex: <15 Male 2017 2,390
TX_CURR Aggregated Age/Sex: 15+ Female 2017 41,891
TX_CURR Aggregated Age/Sex: 15+ Male 2017 20,681
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2017 67,218
TX_CURR Sum of age/sex disaggregates 2017 2,792
TX_CURR Sum of Aggregated Age/Sex <15 2017 4,646
TX_CURR Sum of Aggregated Age/Sex 15+ 2017 62,572
TX_CURR Sum of Aggregated Age/Sex disaggregates 2017 67,218
TX_NEW Aggregated Grouping by Age/Sex: <15 Female 2017 290
TX_NEW Aggregated Grouping by Age/Sex: <15 Male 2017 292
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2017 7,188
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2017 3,716
TX_NEW By Age/Sex: <1 2017 51
TX_NEW By Age/Sex: 1-9 2017 410
TX_NEW By Age/Sex: 10-14 Female 2017 77
TX_NEW By Age/Sex: 10-14 Male 2017 63
TX_NEW By Age/Sex: 15-19 Female 2017 243
TX_NEW By Age/Sex: 15-19 Male 2017 53
TX_NEW By Age/Sex: 20-24 Female 2017 979
TX_NEW By Age/Sex: 20-24 Male 2017 175
TX_NEW By Age/Sex: 25-49 Female 2017 5,448
TX_NEW By Age/Sex: 25-49 Male 2017 3,002
TX_NEW By Age/Sex: 50+ Female 2017 518
TX_NEW By Age/Sex: 50+ Male 2017 486
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2017 11,486
TX_NEW Sum of Age/Sex disaggregates 2017 11,044
TX_NEW Sum of Aggregated Age/Sex disaggregates 2017 11,486
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2017 60,509
TX_PVLS Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2017 60,509
TX_PVLS Numerator Aggregated Age/Sex: <15 Female 2017 2,034
TX_PVLS Numerator Aggregated Age/Sex: <15 Male 2017 2,157
TX_PVLS Numerator Aggregated Age/Sex: 15+ Female 2017 37,702
TX_PVLS Numerator Aggregated Age/Sex: 15+ Male 2017 18,616
TX_PVLS Numerator: Indication: Routine 2017 60,509
TX_PVLS_den Denominator Aggregated Age/Sex: <15 Female 2017 2,034
TX_PVLS_den Denominator Aggregated Age/Sex: <15 Male 2017 2,157
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Female 2017 37,702
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Male 2017 18,616
TX_PVLS_den Denominator: Indication: Routine 2017 60,509
TX_RET Age/Sex: <1 (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 50
TX_RET Age/Sex: 1-9 (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 358
TX_RET Age/Sex: 10-14 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 71
TX_RET Age/Sex: 10-14 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 60
TX_RET Age/Sex: 15-19 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 216
TX_RET Age/Sex: 15-19 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 51
TX_RET Age/Sex: 20-24 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 883
TX_RET Age/Sex: 20-24 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 159
TX_RET Age/Sex: 25-49 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 4,892
TX_RET Age/Sex: 25-49 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 2,700
TX_RET Age/Sex: 50+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 463
TX_RET Age/Sex: 50+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 440
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 270
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 269
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 6,454
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 3,350
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2017 10,343
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2017 11,486
TX_RET_den Age/Sex: >1 (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 51
TX_RET_den Age/Sex: 1-9 (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 391
TX_RET_den Age/Sex: 10-14 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 77
TX_RET_den Age/Sex: 10-14 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 63
TX_RET_den Age/Sex: 15-19 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 243
TX_RET_den Age/Sex: 15-19 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 53
TX_RET_den Age/Sex: 20-24 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 979
TX_RET_den Age/Sex: 20-24 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 175
TX_RET_den Age/Sex: 25-49 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 5,448
TX_RET_den Age/Sex: 25-49 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 3,002
TX_RET_den Age/Sex: 50+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 518
TX_RET_den Age/Sex: 50+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 486
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 290
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 292
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 7,188
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 3,716
VMMC_CIRC By Age: 10-14 2017 15,427
VMMC_CIRC By Age: 15-19 2017 4,172
VMMC_CIRC By Age: 20-24 2017 883
VMMC_CIRC By Age: 25-29 2017 875
VMMC_CIRC By Age: 30-49 2017 1,134
VMMC_CIRC By Age: 50+ 2017 79
VMMC_CIRC By circumcision technique: Device-based VMMC 2017 1,500
VMMC_CIRC By circumcision technique: Surgical VMMC 2017 21,069
VMMC_CIRC Number of males circumcised as part of the voluntary medical male circumcision (VMMC) for HIV prevention program within the reporting period 2017 22,569
VMMC_CIRC Sum of age disaggregates (FY15-Current) 2017 22,570
VMMC_CIRC Sum of age disaggregates (Prior to FY15) 2017 20,561